PALATINE, Ill., Oct. 27, 2008 (GLOBE NEWSWIRE) -- Acura Pharmaceuticals, Inc. (Nasdaq:ACUR) today reported 2008 third quarter net income of $3.1 million, or $0.06 per diluted share compared to a net loss of $2.5 million, or a ($0.06) loss per share for the same quarter in 2007. For the nine months ending September 30, 2008, the Company reported net income of $17.5 million, or $0.35 per diluted share compared to a net loss of $13.8 million or a ($0.37) loss per share for the same period in 2007. As of October 24, 2008, we had cash and cash equivalents of approximately $35.0 million with no term indebtedness.
